Johnson & Johnson Vision drug eluting contact lens acuvue Theravision_FDA Revised Carton
[Image from Johnson & Johnson Vision]

Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards.

The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 hours without the need for allergy drops while also providing vision correction, received FDA approval in March.

Get the full story at our sister site, Drug Delivery Business News.